Joel S. Bennett, MD
Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-1378.
Requests for Single Reprints: Joel S. Bennett, MD, Hematology-Oncology Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Room 814, BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104; e-mail, firstname.lastname@example.org.
Joel S. Bennett. Are Antiplatelet Agents Beneficial in Essential Thrombocythemia? Maybe Yes, Probably No. Ann Intern Med. 2017;167:206–207. doi: 10.7326/M17-1378
Download citation file:
Published: Ann Intern Med. 2017;167(3):206-207.
Published at www.annals.org on 27 June 2017
Coagulopathies, Hematology/Oncology, Platelet Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use